Acousia Therapeutics GmbH
PrivateLast Round
VC Round
Jan 9, 2024
Total Funding Raised
$14.43M
Momentum Score
25 /100
Company Overview
Acousia Therapeutics GmbH is a biotechnology company that develops small molecule drugs for the treatment and prevention of sensorineural hearing loss.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Acousia Therapeutics GmbH Comps
Public and private peers based on sector, stage, and business model.
Acousia Therapeutics GmbH Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jan 9, 2024 | ||||
| Series B | May 14, 2018 | ||||
| Series A | Dec 14, 2016 | ||||
| Seed | Sep 24, 2012 |
Acousia Therapeutics GmbH Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Esperante Ventures | VC Round |
| Boehringer Ingelheim Venture Fund | Series B, Series A, Seed |
| KfW | Series A, Series B |
| LBBW Venture Capital | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 20, 2026
Monthly visitors grew 238% MoM, reaching 1.3K.
Acousia Therapeutics GmbH Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Acousia Therapeutics GmbH's valuation, stock price, and market status.
